arrow
A

Alexey A. Lugovskoy

merrimack pharmaceuticals, inc.
H指数:37
被引数:7,873

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antitumour activity and tolerability of an EphA2-targeted nanotherapeutic in multiple mouse models
2019-04-0552
PREAI
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM

MM-131是一种双特异性抗Met/EpCAM mAb,通过同时结合EpCAM抑制HGF依赖性和HGF非依赖性Met信号

2019-03-2130
OAAI
Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer
2018-06-1450
OAAI
Preclinical characterization and first-in-human study of MM-141, a dual antibody inhibitor of IGF-1R and ErbB3
2015-08-013
PRE